Business

Review Opinions of the Remuneration and Appraisal Committee of the Board of Directors and Public Disclosure of the List of Recipients for the Initial Grant under the Company's 2025 Stock Option Incentive Plan

Review Opinions of the Remuneration and Appraisal Committee of the Board of Directors and Public Disclosure of the List of Recipients for the Initial Grant under the Company's 2025 Stock Option Incentive Plan

articleJiangsu Aidea Pharmaceutical Group Co., Ltd. Class AJuly 7, 20253/news/review-opinions-of-the-remuneration-and-appraisal-committee-of-the-board-of-directors-and-public-disclosure-of-the-list-of-recipients-for-the-initial-grant-under-the-companys-2025-stock-option-incentive-plan
Review Opinions of the Remuneration and Appraisal Committee of the Board of Directors and Public Disclosure of the List of Recipients for the Initial Grant under the Company's 2025 Stock Option Incentive Plan

About this update from Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A

Review Opinions of the Remuneration and Appraisal Committee of the Board of Directors and Public Disclosure of the List of Recipients for the Initial Grant under the Company's 2025 Stock Option Incentive PlanThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A